All News


All series


All All News

SNMMI 2026: Highlighted Interviews

Catch up on recent interviews with Michael Hofman, MBBS, FRACP, Heather Jacene, MD, Phillip Kuo, MD, and more discussing new research and advances presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2026 conference.

Radiology Self-Appraisal: Bane or Boon?

While perspective is important for reining in an unrelenting perfectionism here and there, the inner drive for achievement can serve as fuel for consistently high quality over the course of a radiologist’s career.

FDA Approves Low-Dose MRI Contrast Agent Gadoquatrane

FDA Approves Low-Dose MRI Contrast Agent Gadoquatrane

Published: | Updated:

Indicated for the detection and visualization of abnormal vascularity in the central nervous system (CNS) and non-CNS body regions, gadoquatrane provides 60 percent less gadolinium dosing in comparison to other macrocyclic gadolinium (Gd)-based contrast agents (mGBCAs).

Addressing Challenges in Radiology Reporting

In a recent interview, Nina Kottler, MD, discussed the challenges with traditional radiology reporting, its impact on cognitive load and the recently launched AI-enabled platform Mosaic Reporting.